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INTRODUCTION
Preterm labor is still a problem in obstetrics and peri-
natology since it deals with high rates of infant mor-
bidity and mortality. The incidence of preterm labor
is ± 7 - 8% of all deliveries contributing ± 85% in
perinatal deaths.1
In developing countries the number of events was
much higher, which were, around 30% in India, 15%
in South Africa, 31% in Sudan, and 10% in Malay-
sia.2 Alisjahbana et al, reported the incidence of pre-
term labor in Dr. Hasan Sadikin Hospital (RSHS)
Bandung to be 17.4%.3 The annual report of Obste-
trics and Gynecology RSHS Bandung, obtain a num-
ber of 18% preterm labor from all deliveries and it
has not changed over the last 10 years.4
According to Green et al, more than 60% of pre-
term labor cannot be explained, it is generally only
described as idiopathic preterm labor and premature
rupture of membranes. Some experts argue that these
two things are associated with subclinical inflamma-
tory response in fetal and maternal tissues.5
The mechanism of preterm labor is still being de-
bated. Lockwood et al., stated that there were four
mechanisms that may lead to preterm labor; Activa-
tion of the hypothalamic-pituitary-adrenal axis (HPA)
of the fetus and the mother, systemic inflammation
or inflammation on decidua and chorioamnion, deci-
dual hemorrhage, pathologic uterine distension such
as multiple pregnancy, polyhydramnios, and uterine
abnormalities.6 Several studies have been conducted
to predict the occurrence of preterm labor.7 Currently,
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Abstrak
Tujuan: Penelitian ini adalah menganalisis perbedaan kadar
serum Magrophage Migration Inhibitory Factor (MIF) antara ke-
hamilan dan persalinan 28 - 36 minggu dan menganalisis kadar se-
rum Magrophage Migration Inhibitory Factor (MIF) yang meru-
pakan faktor risiko kejadian persalinan kurang bulan.
Metode: Rancangan penelitian ini adalah potong silang (cross
sectional) terhadap 72 subjek penelitian yang memenuhi kriteria
inklusi dan eksklusi yang datang ke RS Dr. Hasan Sadikin Bandung
dan enam rumah sakit jejaring periode Juli - Agustus 2011. Kadar
serum MIF diperiksa dengan ELIZA. Perbandingan rerata kadar
serum Macrophage Migration Inhibitory Factor (MIF) antara ke-
hamilan dan persalinan 28 - 36 minggu menggunakan uji Mann Whit-
ney, dan kadar MIF yang merupakan penentu persalinan kurang bu-
lan dihitung dengan ratio prevalen (PR) berdasarkan kurva ROC.
Hasil: Uji karakteristik pada kedua kelompok penelitian menun-
jukkan kedua kelompok homogen dan dapat diperbandingkan. Rera-
ta kadar Macrophage Migration Inhibitory Factor (MIF) pada per-
salinan 28-36 minggu lebih tinggi (54,433 ng/ml) dibandingkan de-
ngan kehamilan 28-36 minggu (31,765 ng/ml) (p ≤ 0,001). Kadar MIF
> 37,684 ng/ml mempunyai risiko kejadian persalinan kurang bulan
3,35 kali lebih besar dibandingkan kadar MIF ≤ 37,684 ng/ml.
Kesimpulan: Kadar serum Macrophage Migration Inhibitory
Factor (MIF) pada persalinan lebih tinggi dari kehamilan 28 - 36
minggu. Kadar MIF > 37,684 merupakan faktor risiko kejadian per-
salinan kurang bulan.
[Maj Obstet Ginekol Indones 2011; 35-3: 115-8]
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many studies are focused on targeting bio-chemical
markers of preterm labor analyzing a variety of cy-
tokines and extracellular matrix of fetal membranes,
cytotrophoblasts, decidua or cervix.
One of the proinflammatory cytokine, MIF, is con-
tributing to initiation of preterm labor. MIF is a potent
cytokine, that can be produced by various cell types
and normal tissue, macrophage, monocytes, endo-
crine, and the reproductive organs. MIF is considered
as a major mediator in the inflammatory response. Re-
cent studies have shown that MIF is a cytokine that
plays a role in maintaining pregnancy.8 MIF induces
the synthesis of other pro-inflammatory mediators
such as TNF-α, IL-1, IL-6, IL-8 and has a unique
ability to inhibit steroid suppression on cytokine syn-
thesis. Moreover MIF is a potent activator of macro-
phages, which induces various biological functions of
these cells such as adhesion, phagocytosis, intracellu-
lar parasite eradication and introduction of nitric ox-
ide production.8
Up to now, few studies have been done to find-out
the relationship between MIF and preterm labor. Pearce
et al, stated that levels of MIF measured in trimesters I
and II could used to predict the incidence of premature
labor, with a cut-off point of 9.16 ng/ml.9
METHOD
Our study design was cross sectional of seventy-two
patients who met the inclusion- and exclusion-criteria
that came to our outpatient clinic at Dr. Hasan Sadikin
Hospital Bandung and six satelite hospital between
July and August 2011. Comparison of the mean serum
levels of MIF between 28 - 36 weeks of pregnancy
and delivery was analyzed using the Mann Whitney
test. MIF level, which is risk factor for preterm de-
livery, was calculated with a prevalence ratio (PR)
based on ROC curve.
RESULTS
Serum levels of MIF in 28 - 36 weeks of pregnancy
and delivery were obtained with a cross-sectional
study of 72 patients who met the inclusion- and ex-
clusion-criteria.
Table 1 showed that there was no difference in the
characteristics of patients based on age, parity, gesta-
tional age, and asymptomatic bacteriuria between 28
- 36 weeks of pregnancy and delivery with p value
of 0.691, 0.222, 0.616, 0.301, 1.0, respectively. There-
fore, both groups were comparable.
Table 2. Comparison of serum levels of Macrophage Migra-
tion Inhibitory Factor (MIF) between mothers 28-36 weeks of
pregnancy and delivery.
Variable
Research Group
p value*)28 - 36 Weeks
Delivery (n=36)
28 - 36 Weeks
Pregnancy (n=36)
MIF Level’s < 0.001
Mean(±SD) 54.433 (25.797) 31.765 (9.654)
Median 48.026 29.500
Range 21.199 - 119.796 19.708 - 58.820
*) Mann Whitney test
Table 1. Characteristics of patients.
Characteristics
Research Group
p value*)28 - 36 Weeks Delivery (n = 36) 28 - 36 Weeks Pregnancy (n = 36)
N % N %
Age (year) 0.691
< 20  4 11.1  2  5.6
20 - 35 27 75.0 29 80.6
> 35  5 13.9  5 13.9
Parity 0.222
P 0 13 36.1 10 27.8
P 1 - 3 19 52.8 25 69.4
P ≥ 4  4 11.1  1  2.8
Gestational Age (Weeks) 0.616
28 - 30 11 30.6 15 41.7
31 - 33 11 30.6  9 25.0
34 - 36 14 38.9 12 33.3
Bacteriuria 0.306
Positif  9 25.0 13 36.1
Negatif 27 75.0 23 63.9
Stress 1.0**)
Yes  4 11.1  3  8.3
No 32 88.9 33 91.7
*) Chi Square test
**) Fisher’s exact test
Indones J
116  Riyanti et al Obstet Gynecol
Table 2 showed that there were significantly dif-
ferent levels of serum Macrophage MIF between 28
- 36 weeks of pregnancy and delivery with p value
of p < 0.001.
According to ROC curve (receiver operating char-
acteristics), cut-off point serum level of Magrophage
Migration Inhibitory Factor (MIF) in 28 - 36 weeks
of delivery was > 37.684 ng/ml With an area under
the ROC curve being 0.806 showing a good validity.
Table 3 showed that the prevalence ratio value
(PR) of Macrophage MIF serum of 28 - 36 weeks
delivery was 3.35, which indicated that Macrophage
MIF levels > 37.684 had 3.35 times risk for preterm
labor. Validity test on the serum Macrophage MIF of
28 - 36 weeks delivery showed a sensitivity of 75.0%,
specificity 80.6%, 79.4% positive expected value,
76.3% negative expected value, and an accuracy of
77.8% at a cut-off point of 37.684.
DISCUSSION
Characteristics of Research Subjects
From epidemiological point of view, there are several
risk factors for preterm labor, which are:10-2 Idi-
opathic, factors, iatrogenic, factors Infections (both
extra- and intra-uterine), Maternal factors (maternal
disease, cervical incompetence, and stress), reproduc-
tive history (a history of previous prematurity, primi-
parity, parity, short interval of two pregnancies, low
maternal weight during pregnancy), sociodemogra-
phic (low socioeconomic status, age is too young or
too old, race, marital status, unfavorable environmen-
tal factors, heavy physical activities).
Maternal age that is too young or too old is a risk
factor for preterm labor. A study in Sweden stated
that pregnant women with an age between 13 - 17
years and more than 35 years have an increases risk
of preterm labor two times the control group of wo-
men aging 20 - 30 years.12
Preterm labor is more common in the first preg-
nancies. Incidence will be reduced by increasing the
number of parity sufficient months to the fourth pari-
ty.12 The incidence of asymptomatic bacteriuria urine
was approximately 2 - 7% of all pregnancy.13 Ac-
cording to Sheiner et al, of 199.093 deliveries; 2.5%
(4890) of patients experienced asymptomatic bacteri-
uria, with E.Colli as the most isolated bacteria.14
Moutquin et al, proved that stress associated with an
incidence of prematurity consisted of events of death,
domestic violence and financial problems.15
In our study, both treatment groups were homoge-
neous for age, parity, gestational age, asymptomatic
bacteriuria and stress between 28 - 36 weeks of preg-
nancy and delivery, thus reasonable so worthy to be
compared.
Comparison of Macrophage Migration Inhibitory
Factor Serum Levels between 28 - 36 Weeks Preg-
nancy and Delivery
Serum levels of MIF increased among pregnant wo-
men than non-pregnant women, but there was no sig-
nificant change in MIF levels between the first tri-
mester of pregnancy, the second and the third.16
According Ietta et al, serum levels of MIF did not
change with increasing gestational age median of
4.32 ng/ml, interval 0.60 - 21.33 for gestation of pre-
term labor.8
According Chaiworapongsa et al, there was no dif-
ference in plasma MIF levels among patients with
preterm contractions and intact membranes, preterm
and full term delivery (full term delivery; n = 18),
median 52 ng/ml, interval 24-152; preterm labor, n =
27), median 55 ng/ml, range 13-160).17
According to Pearce et al, there were differences
in MIF serum levels among women who gave birth
full term and prematurely when measured in at 9 -
23 weeks of gestation with a median of 9.22 ng/ml
(6.22 - 12.06) for women who premature delivery and
a median of 7.00 ng/ml (5.64 - 9.17) for the full
termed.9
This study indicated that there were different levels
of serum MIF between 28 - 36 weeks of pregnancy
and delivery.
Analysis of MIF Level as a Risk Factor for Pre-
term Labor
Some types of infection associated with preterm labor
include: urinary tract infections, cervicitis, bacterial
vaginosis, trichomoniasis and several others, such as
candida vaginal, group B streptococcus, N gonorrho-
eae, U urealyticum.18-20
Research on types of work and physical activities
stated that conditions of stress, and hard work in the
long hours were associated with preterm birth.6 Ac-
cording to Pearce et al, increased MIF is associated
with a diagnosis of bacterial vaginosis (BV) in early
pregnancy.9
In this study we obtained prevalence ratio (PR) of
3.35 which indicates that when levels of Macrophage
MIF is > 37.684 ng/ml the risk for preterm delivery
Table 3. Serum levels of Macrophage MIF based on ROC curve (Receiver Operating Characteristics) between 28 - 36 weeks preg-
nancy and delivery.
Variable
Research Group
p value*) PR (95%CI)28 - 36 Weeks Delivery (n = 36) 28 - 36 Weeks Pregnancy (n = 36)
N % N %
MIF Level’s < 0.001 3.35 (1.85 - 6.08)
  > 37.684 27 75.0  7 19.4
  ≤ 37.684  9 25.0 29 80.6
*) Chi Square test
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becomes 3.35 times greater than if levels of migration
inhibitory factor Macrophage (MIF) is lower at ≤
37.684 ng/ml.
CONCLUSION
The mean levels of MIF in deliveries that happen in
28 - 36 weeks of gestational age are higher compared
with 28 - 36 of weeks pregnancy. Level of Macro-
phage Migration Inhibitory Factor (MIF) > 37.684 is
a risk factor for preterm labor increasing incidence
by 3.35 times compared to level of MIF ≤ 37.684.
REFERENCES
1. Rush RW, Keirse MJN, Howat P, Baum JD, Anderson
ABM, Turnbull AC. Contribution of preterm delivery to
perinatal mortality. Br Med J 1996; 2: 965-8
2. Goldenberg RL, JF Culhane, IAMS JD, Romero R. Epide-
miology and causes of preterm birth. The Lancet. 2008;
271(9606): 75-84
3. Alisjahbana A, Hamzah ES, Tanuwidjaja S. Perinatal mor-
tality and morbidity survey and low birth weight. Final Re-
port. 1983; V
4. Krisnadi SR. The Use of Clindamycin to Reduce LBW in-
fant rate applied to Bacterial Vaginosis, with or without
Group B Streptococcal Colonization dan Chlamydia Tra-
chomatis infection. Bandung: Padjadjaran University; 2000
5. Christiaens I, Zaragoza DB, Guilbert L, Robertson SA, Mit-
chell BF, Olson DM. Inflammatory processes in preterm
and term parturition. J Reprod Immunol. 2008; 79(1): 50-7
6. Lockwood CJ. Risk stratification and pathological mecha-
nisms in preterm delivery. Pediatric and perinatal epidemio-
logy. 2001: 79-89
7. Gibbs RS, Romero R, Hillier SL, Eschenbach DA, Sweet
RL. A review of premature birth and subclinical infection.
Am J Obstet Gynecol 1992; 166: 1515-28
8. Ietta F, Todros T, Ticconi C, Piccoli E, Zicari A, Piccione
E. Macrophage migration inhibitory factor in human preg-
nancy and labor. Am J Reprod Immunol 2002; 48: 404-9
9. Pearce BD GS, Grove J. Serum macrophage migration in-
hibitory factor in the prediction of preterm delivery. Am J
Obstet Gynecol 2008; 199(46): 146
10. McGuire W, Fowlie PW. ABC of preterm birth. Malden,
Mass: BMJ Books/Blackwell Pub. 2005
11. Swadpanich U, Lumbiganon P, Prasertcharoensook W, La-
opaiboon M. Antenatal lower genital tract infection screen-
ing and treatment programs for preventing preterm delive-
ry. Cochrane Database Syst Rev. 2008(2): CD006178
12. Greer I, Norman J. Preterm Labor, Managing risk in clini-
cal practice. Cambridge University Press. 2005: 1-26
13. Cram L, Zapata M, Toy E, Baker B. Genitourinary infec-
tion and their association with preterm labour. Am Fam
Physician. 2002; 65(2): 241-9
14. Sheiner E, Mazor-Drey E, Levy A. Asymptomatic bacteri-
uria during pregnancy. J Matern Fetal Neonatal Med. 2009;
22(5): 423-7
15. Moutquin JM. Socio-economic and psychosocial factors in
the management and prevention of preterm labour. BJOG.
2003; 110 Suppl 20: 56-60
16. Vigano P, Cinterino M, Schatz F, Lockwood CJ, Arcuri F.
The role of magrophage migration inhibitory factor in
maintaining the immune privilege at the fetal-maternal in-
terface. Semin Immunopathol. 2007; 29: 135-50
17. Chaiworapongsa T, Romero R, Espinoza J, Kim YM, Ed-
win S, Bujold E, Gomez R, Kuivaniemi H. Macrophage
migration inhibitory factor in patients with preterm partu-
rition and microbial invasion of the amniotic cavity. J Ma-
tern Fetal Neonatal Med 2005; 18: 405-16
18. Romero R, Gomez R, Chaiworapongsa T, Conoscenti G,
Kim JC, Kim YK. The role of infection in preterm labour
and delivery. Blackwell Science. 2001; 15(2): 41-56
19. Klein LL, Gibbs RS. Infection and preterm birth. Obst Gy-
necol Clin North Am. 2005; 32: 397-410
20. Swadpanich U, Lumbiganon P, Laopaiboon WPM. Ante-
natal lower genital tract infection screening and treatment
programs for preventing preterm delivery. The Cochrane
Library. 2008: 4
Indones J
118  Riyanti et al Obstet Gynecol
